company

BROADVIEW LIFESCIENCE AS

0571 OSLO

Return on Equity
−111,54 %
Current Ratio
0,88
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue1 110 000
Net Income29 000
Total Assets181 000
Total Equity−26 000
Income (NOK)2022
Revenue1 110 000
Expenditure1 081 000
Operating Profit29 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax29 000
Tax0
Net Income29 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets181 000
Total Assets181 000
Total Retained Equity−1 026 000
Total Equity−26 000
Total Long-Term Debt0
Total Current Debt206 000
Total Equity and Debt181 000
Cash flow (NOK)2022
Sales Income1 110 000
Other Income0
Revenue1 110 000
Cost of Goods Sold999 000
Salary Costs0
Depreciation0
Impairment0
Expenditure1 081 000
Operating Profit29 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income29 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank155 000
Total Current Assets181 000
Total Assets181 000
Total Equity−26 000
Short-Term Group Debt196 000
Total Long-Term Debt0
Creditors0
Unpaid Taxes11 000
Dividends0
Other Current Debt0
Total Current Debt206 000
Total Equity and Debt181 000
Financial indicators2022
Return on Equity−111,54 %
Debt-to-Equity Ratio−0
Operating Profit Margin2,61 %
Current Ratio0,88
Quick Ratio0,88
Equity Ratio−0,14
Gross Profit Margin10 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English